Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semi-continuous Intra-oral Levodopa/Carbidopa in Advanced PD
NCT02763137Phase 2Completed
- Sponsor
- Fondazione San Raffaele Monte Tabor
- Start
- Jul 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa, carbidopa in Parkinson's disease (PD), sponsored by Fondazione San Raffaele Monte Tabor. Started Jul 2014; status: completed.
02
Drugs
levodopacarbidopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02763137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02763137.